5.56
Aldeyra Therapeutics Inc (ALDX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Research and Development |
14.57%
8.5052
|
7.4233 | 12.44 | 14.97 | 6.1835 |
Operating Income/Loss |
2.48%
-10.17
|
-10.43 | -16.14 | -18.01 | -9.3939 |
Nonoperating Income/Loss |
19.39%
0.4014
|
0.498 | 1.0246 | 1.1602 | 1.3117 |
Income/Loss From Continuing Operations Before Tax |
1.63%
-9.7673
|
-9.9295 | -15.11 | -16.85 | -8.0821 |
Income/Loss From Continuing Operations After Tax |
1.63%
-9.7673
|
-9.9295 | -15.11 | -16.85 | -8.0821 |
|
1.63%
-9.7673
|
-9.9295 | -15.11 | -16.85 | -8.0821 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.26%
60.05
|
59.89 | 59.53 | 59.41 | 59.41 |
Diluted Average Shares |
0.26%
60.05
|
59.89 | 59.53 | 59.41 | 59.41 |
Basic Earnings Per Share |
5.88%
-0.16
|
-0.17 | -0.25 | -0.28 | -0.14 |
Diluted Earnings Per Share |
5.88%
-0.16
|
-0.17 | -0.25 | -0.28 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):